Propofol cardioplegia: A single-center, placebo-controlled, randomized controlled trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 6, 2015, Pages 1610-1619.e13

  Rogers, Chris A ^a   Bryan, Alan J ^b   Nash, Rachel ^a   Suleiman, M Saadeh ^b   Baos, Sarah ^a   Plummer, Zoe ^a   Hillier, James ^b   Davies, Ian ^b   Downes, Richard ^b   Nicholson, Eamonn ^b   Reeves, Barnaby C ^a   Angelini, Gianni D ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

AVR; CABG; Cardioplegia; Cardiopulmonary bypass; Propofol

Indexed keywords

CARDIOPLEGIC AGENT; INOTROPIC AGENT; INTRALIPID; PROPOFOL; TROPONIN T; VASODILATOR AGENT; EMULSION; PHOSPHOLIPID; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ATRIAL FIBRILLATION; CARDIOPLEGIA; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIGESTIVE SYSTEM PERFORATION; DIVERTICULOSIS; DOUBLE BLIND PROCEDURE; FEMALE; FORWARD HEART FAILURE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HEART PACING; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HEMOFILTRATION; HUMAN; INTENSIVE CARE; INTRAAORTIC BALLOON PUMP; KIDNEY FUNCTION; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PERIPHERAL ISCHEMIA; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RETINA MACULOPATHY; SEPSIS; SUPRAVENTRICULAR TACHYCARDIA; THORAX PAIN; ADMINISTRATION AND DOSAGE; AORTA VALVE; EMULSION; HEART ARREST; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; METABOLISM; MIDDLE AGED; PROCEDURES; TREATMENT OUTCOME;

ADULT; AGED; AORTIC VALVE; CARDIOPLEGIC SOLUTIONS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; EMULSIONS; FEMALE; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROPOFOL; SOYBEAN OIL; TREATMENT OUTCOME; TROPONIN T;

EID: 84948720722     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.06.044     Document Type: Article

References (35)

1. D.J. Chambers, and H.B. Fallouh Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion Pharmacol Ther 127 2010 41 52
2. J. Vinten-Johansen, and V.H. Thourani Myocardial protection: an overview J Extra Corpor Technol 32 2000 38 48
3. E. Murphy, and C. Steenbergen Ion transport and energetics during cell death and protection Physiology (Bethesda) 23 2008 115 123
4. F.P. Tritto, J. Inserte, D. Garcia-Dorado, M. Ruiz-Meana, and J. Soler-Soler Sodium/hydrogen exchanger inhibition reduces myocardial reperfusion edema after normothermic cardioplegia J Thorac Cardiovasc Surg 115 1998 709 715
5. D. Garcia-Dorado, and J. Oliveras Myocardial oedema: a preventable cause of reperfusion injury? Cardiovasc Res 27 1993 1555 1563
6. M. Ruiz-Meana, D. Garcia-Dorado, M.A. Gonzalez, J.A. Barrabes, and J. Soler-Soler Effect of osmotic stress on sarcolemmal integrity of isolated cardiomyocytes following transient metabolic inhibition Cardiovasc Res 30 1995 64 69
7. A.P. Halestrap, and P. Pasdois The role of the mitochondrial permeability transition pore in heart disease Biochim Biophys Acta 1787 2009 1402 1415
8. Q. Chen, A.K. Camara, D.F. Stowe, C.L. Hoppel, and E.J. Lesnefsky Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion Am J Physiol Cell Physiol 292 2007 C137 C147
9. A.P. Halestrap Mitochondria and reperfusion injury of the heart-a holey death but not beyond salvation J Bioenerg Biomembr 41 2009 113 121
10. N.S. Dhalla, R.M. Temsah, and T. Netticadan Role of oxidative stress in cardiovascular diseases J Hypertens 18 2000 655 673
11. A.P. Halestrap A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection Biochem Soc Trans 38 2010 841 860
12. M.S. Suleiman, K. Zacharowski, and G.D. Angelini Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics Br J Pharmacol 153 2008 21 33
13. W. Yang, H. Li, H. Luo, and W. Luo Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model Life Sci 88 2011 302 306
14. M.S. Suleiman, A.P. Halestrap, and E.J. Griffiths Mitochondria: a target for myocardial protection Pharmacol Ther 89 2001 29 46
15. J.G. Bovill Intravenous anesthesia for the patient with left ventricular dysfunction Semin Cardiothorac Vasc Anesth 10 2006 43 48
16. N. Kamada, N. Kanaya, N. Hirata, S. Kimura, and A. Namiki Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3beta Can J Anaesth 55 2008 595 605
17. Z. Xia, D.V. Godin, T.K. Chang, and D.M. Ansley Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation Can J Physiol Pharmacol 81 2003 14 21
18. C. Lin, H. Sui, J. Gu, X. Yang, L. Deng, W. Li, and et al. Effect and mechanism of propofol on myocardial ischemia reperfusion injury in type 2 diabetic rats Microvasc Res 90 2013 162 168
19. N. King, M. Al Shaama, and M.S. Suleiman Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion Pflugers Arch 464 2012 513 522
20. S.A. Javadov, K.H. Lim, P.M. Kerr, M.S. Suleiman, G.D. Angelini, and A.P. Halestrap Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition Cardiovasc Res 45 2000 360 369
21. I. Kobayashi, N. Kokita, and A. Namiki Propofol attenuates ischaemia-reperfusion injury in the rat heart in vivo Eur J Anaesthesiol 25 2008 144 151
22. K.H. Lim, A.P. Halestrap, G.D. Angelini, and M.S. Suleiman Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass Exp Biol Med (Maywood) 230 2005 413 420
23. Z.E. Plummer, S. Baos, C.A. Rogers, M.S. Suleiman, A.J. Bryan, G.D. Angelini, and et al. The effects of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients with isolated coronary artery bypass grafting or aortic valve replacement using cardiopulmonary bypass: protocol for a single-center randomized controlled trial JMIR Res Protoc 3 2014 e35
24. M. Caputo, R. Ascione, G.D. Angelini, M.S. Suleiman, and A.J. Bryan The end of the cold era: from intermittent cold to intermittent warm blood cardioplegia Eur J Cardiothorac Surg 14 1998 467 475
25. R. Ascione, M. Caputo, W.J. Gomes, A.A. Lotto, A.J. Bryan, G.D. Angelini, and et al. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia Eur J Cardiothorac Surg 21 2002 440 446
26. C.L. Soraas, C. Friis, K.V. Engebretsen, L. Sandvik, S.E. Kjeldsen, and T. Tonnessen Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery Am Heart J 164 2012 779 785
27. A.A. Mohammed, A.K. Agnihotri, R.R. van Kimmenade, A. Martinez-Rumayor, S.M. Green, R. Quiroz, and et al. Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery Circulation 120 2009 843 850
28. M.H. Rosner, and M.D. Okusa Acute kidney injury associated with cardiac surgery Clin J Am Soc Nephrol 1 2006 19 32
29. G.J. Murphy, K. Pike, C.A. Rogers, S. Wordsworth, E.A. Stokes, G.D. Angelini, and et al. Liberal or restrictive transfusion after cardiac surgery N Engl J Med 372 2015 997 1008
30. B. Bein, J. Renner, D. Caliebe, J. Scholz, A. Paris, S. Fraund, and et al. Sevoflurane but not propofol preserves myocardial function during minimally invasive direct coronary artery bypass surgery Anesth Analg 100 2005 610 616
31. D.T. Andrews, A.G. Royse, and C.F. Royse Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops Br J Anaesth 103 2009 654 664
32. Z. Xia, Z. Huang, and D.M. Ansley Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane Anesth Analg 103 2006 527 532
33. Z. Huang, X. Zhong, M.G. Irwin, S. Ji, G.T. Wong, Y. Liu, and et al. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients Clin Sci (London) 121 2011 57 69
34. E. Kottenberg, M. Thielmann, L. Bergmann, T. Heine, H. Jakob, G. Heusch, and et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial Acta Anaesthesiol Scand 56 2012 30 38
35. E. Kottenberg, J. Musiolik, M. Thielmann, H. Jakob, J. Peters, and G. Heusch Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting J Thorac Cardiovasc Surg 147 2014 376 382